OPX Biotechnologies, Inc.: Series B $17.5M

Posted in I - Series B, Q - 2Q09, R - ROCKY MOUNTAIN, X - Biofuel, X - Metabolism, XX - CO

OPX Biotechnologies (Boulder, CO) a research-stage biofuels company using synthetic biology to engineer the microbes as a renewable fuel source, added to their Series B financing bringing the round up to $17.5M. Participants include Braemar Energy Ventures, Altira Group, Mohr Davidow Ventures and X/Seed Capital.

CeraPedics, Inc.: Series B $15M

Posted in I - Series B, Q - 2Q09, R - ROCKY MOUNTAIN, X - Bone Graft, XX - CO

CeraPedics (Broomfield, CO) a clinical stage device company focused on osteobiologic products for bony voids, closed a $15M Series B financing. Participants include NGN Capital and OrbiMed Advisors.

BiOptix Diagnostics, Inc.: Series A $3M

Posted in I - Series A, Q - 1Q09, R - ROCKY MOUNTAIN, X - Device (Diagnostic), XX - CO

BiOptix (Boulder, CO) a commercial focused developer of an array-based biomolecule detection system that addresses many markets that currently cannot obtain the needed sensitivity and throughput in a single solution, closed a $3M Series A finacing. Participants include Boulder Ventures.

OPX Biotechnologies, Inc.: Series B $12.1M

Posted in I - Series C, Q - 1Q09, R - ROCKY MOUNTAIN, X - Bioagriculture, X - Biofuel, XX - CO

OPX Biotechnologies (Boulder, CO) a research-stage biofuels company using synthetic biology to engineer the microbes as a renewable fuel source closed a $12.1M Series B financing. Participants include Braemar Energy Ventures, Mohr Davidow Ventures and X/Seed Capital.

MD-IT, Inc.: Series B $11M

Posted in I - Series B, Q - 1Q09, R - ROCKY MOUNTAIN, X - TeleMedicine, XX - CO

MD-IT (Boulder, CO) pprovider of medical documentation services and software for physician offices and ambulatory clinics, closed a $11M Series B financing. Participants include J. Burke Capital Partners.

Next Entries »

to top of page...